Exact Sciences
EXAS
#1715
Rank
โ‚ฌ9.51 B
Marketcap
51,39ย โ‚ฌ
Share price
0.74%
Change (1 day)
-13.86%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Earnings for Exact Sciences (EXAS)

Earnings in 2024 (TTM): -โ‚ฌ0.15 Billion

According to Exact Sciences's latest financial reports the company's current earnings are โ‚ฌ2.61 Billion. In 2023 the company made an earning of -โ‚ฌ0.18 Billion, an increase over its 2022 earnings that were of -โ‚ฌ0.6 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exact Sciences from 2001 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚ฌ0.15 Billion-20.09%
2023 -โ‚ฌ0.18 Billion-69.98%
2022 -โ‚ฌ0.6 Billion-25.55%
2021 -โ‚ฌ0.8 Billion1.68%
2020 -โ‚ฌ0.79 Billion271.17%
2019 -โ‚ฌ0.22 Billion58.99%
2018 -โ‚ฌ0.14 Billion20.89%
2017 -โ‚ฌ0.11 Billion-30.95%
2016 -โ‚ฌ0.16 Billion5.09%
2015 -โ‚ฌ0.16 Billion57.24%
2014 -โ‚ฌ96.36 Million116.53%
2013 -โ‚ฌ44.5 Million
2011 -โ‚ฌ27.71 Million143.73%
2010 -โ‚ฌ11.37 Million27.85%
2009 -โ‚ฌ8.9 Million0.27%
2008 -โ‚ฌ8.87 Million-20.95%
2007 -โ‚ฌ11.22 Million-13.53%
2006 -โ‚ฌ12.98 Million-10.07%
2005 -โ‚ฌ14.43 Million-21.81%
2004 -โ‚ฌ18.46 Million-33.44%
2003 -โ‚ฌ27.72 Million-6.51%
2002 -โ‚ฌ29.65 Million17.95%
2001 -โ‚ฌ25.14 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚ฌ0.15 Billion-0.95%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ63.32 M-142.54%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ52.67 Million-64.62%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ33.62 Million-77.42%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ7.12 B-4,883.42%๐Ÿ‡ซ๐Ÿ‡ท France